Article info
Original research
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations
- Correspondence to Dr Dario de Biase, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy; dario.debiase{at}unibo.it; Dr Umberto Malapelle; umberto.malapelle{at}unina.it
Citation
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations
Publication history
- Received February 7, 2021
- Revised March 18, 2021
- Accepted March 18, 2021
- First published April 5, 2021.
Online issue publication
October 18, 2023
Article Versions
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.